| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/05/2006 | EP1642895A2 Novel substituted naphthopyrans |
| 04/05/2006 | EP1641805A1 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 04/05/2006 | EP1641788A1 Preparation of n2-alkylated 1,2,3-triazoles |
| 04/05/2006 | EP1641787A1 Substituted diketopiperazines and their use as oxytocyn antagonists |
| 04/05/2006 | EP1641767A2 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same |
| 04/05/2006 | EP1641764A1 5-membered heterocycle-based p38 kinase inhibitors |
| 04/05/2006 | EP1641759A2 Malonamide derivatives |
| 04/05/2006 | EP1641756A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor |
| 04/05/2006 | EP1641535A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 04/05/2006 | EP1641464A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1641453A2 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 04/05/2006 | EP1305319B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP1019372B1 Fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 04/05/2006 | CN1757066A Optical recording materials having high storage density |
| 04/05/2006 | CN1756748A 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 04/05/2006 | CN1756567A Body weight gain inhibitor |
| 04/05/2006 | CN1756547A 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1249060C Heterofluorene derivative with strong two photon absorption character |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/04/2006 | US7022733 Estrogen receptor modulators for treating or inhibiting endometriosis |
| 04/04/2006 | US7022725 Isoxazole derivatives |
| 04/04/2006 | US7022723 Heterocyclic compounds |
| 04/04/2006 | US7022722 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022705 such as (5RS)-3-(3-Fluoro-4-thiomorpholin-4-yl phenyl)-5-(1,2,3-triazol-1-ylmethyl)-4,5-dihydroisoxazole; antibiotics |
| 04/04/2006 | US7022696 Treatment of airway disorders |
| 04/04/2006 | US7022650 Herbicides for broadleaf/gramineous weeds among crop plants |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 04/04/2006 | CA2241787C Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
| 04/04/2006 | CA2198266C Novel benzimidazole derivatives |
| 04/04/2006 | CA2179284C Substituted unsymmetrical cyanine dyes with selected permeability |
| 04/04/2006 | CA2043976C Substituted phthalides and heterocyclic phthalides |
| 03/31/2006 | WO2005027900A1 Benzofuran derivatives |
| 03/30/2006 | WO2006034474A2 Novel pyridine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | WO2006034473A2 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | WO2006034419A2 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 03/30/2006 | WO2006034116A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 03/30/2006 | WO2006033627A1 Compounds, compositions containing them, preparation thereof and uses thereof iiii |
| 03/30/2006 | WO2006032631A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/30/2006 | WO2006032520A1 Oxazole derivatives as her tyrosine kinase inhibitors |
| 03/30/2006 | WO2006032509A1 Indole derivatives, their manufacture and use as pharmaceutical agents |
| 03/30/2006 | WO2006032453A1 1,2,3 -triazole derivatives as receptor tyrosine kinase inhitors |
| 03/30/2006 | WO2006016724A3 Liquid-crystalline compounds, compositions and thin films |
| 03/30/2006 | WO2006011024A3 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2005117867A3 Monocyclic heterocycles as kinase inhibitors |
| 03/30/2006 | WO2005105769A3 Mycophenolate mofetil impurity |
| 03/30/2006 | WO2005019211A3 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/30/2006 | WO2004113330A8 Immunosuppressant compounds and compositions |
| 03/30/2006 | US20060069262 Oxadiazoles and their manufacture |
| 03/30/2006 | US20060069256 Ophthalmic compositions for treating ocular hypertension |
| 03/30/2006 | US20060069254 Method for the production of alkoxycarbonylamino triazines |
| 03/30/2006 | US20060069253 Aryl-substituted heterocyclic enaminones |
| 03/30/2006 | US20060069135 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex |
| 03/30/2006 | US20060069129 Chemokine receptor binding heterocyclic compounds |
| 03/30/2006 | US20060069109 Therapeutic agents |
| 03/30/2006 | US20060069098 Bone disorders; reduce concentration of parathyroid hormone in blood |
| 03/30/2006 | US20060069095 Azole derivatives |
| 03/30/2006 | US20060069093 Substituted 2H-1,3-benzoxazin-4(3H)-ones |
| 03/30/2006 | US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 03/30/2006 | US20060069077 Receptor-type kinase modulators and methods of use |
| 03/30/2006 | US20060069047 Antibiotic conjugates |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | US20060069034 Antipathogenic benzamide compounds |
| 03/30/2006 | DE102004047840A1 Neue substituierte Thiophencarbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel New substituted thiophenecarboxamides, their preparation and their use as medicaments |
| 03/30/2006 | CA2588280A1 Oxazole derivatives as her tyrosine kinase inhibitors |
| 03/30/2006 | CA2582512A1 Compounds, compositions containing them, preparations thereof and uses thereof ii |
| 03/30/2006 | CA2582492A1 Novel pyrimidine derivatives and their use |
| 03/30/2006 | CA2581657A1 Thrombopoietin receptor agonists |
| 03/30/2006 | CA2581623A1 Novel pyridine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | CA2581338A1 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 03/30/2006 | CA2581172A1 Carbonyl compound-containing drug and the use thereof |
| 03/30/2006 | CA2580725A1 Novel heterocyclic nf-kb inhibitors |
| 03/30/2006 | CA2580621A1 New bicyclic antibiotics |
| 03/30/2006 | CA2580610A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 03/30/2006 | CA2580265A1 Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof |
| 03/30/2006 | CA2579907A1 Carbo- and hetero-cyclic antibiotics and use thereof |
| 03/30/2006 | CA2579412A1 Indole derivatives, their manufacture and use as pharmaceutical agents |
| 03/30/2006 | CA2579408A1 1,2,3 -triazole derivatives as receptor tyrosine kinase inhibitors |
| 03/30/2006 | CA2577799A1 3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors |
| 03/30/2006 | CA2577772A1 Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases |
| 03/29/2006 | EP1640373A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 03/29/2006 | EP1638969A2 Cgrp receptor antagonists |
| 03/29/2006 | EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 03/29/2006 | EP1638963A1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 03/29/2006 | EP1638962A2 Substituted oxyarenes und deren verwendung zur bekämpfung von schädlingen |
| 03/29/2006 | EP1638956A1 2,3-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators |
| 03/29/2006 | EP1638955A2 Pyrimidines useful as modulators of voltage-gated ion channels |
| 03/29/2006 | EP1638954A1 Fused azoles such as 2,5-disubstituted benzimidazoles, benzoxazoles and benzothiazoles as kinase inhibitors |
| 03/29/2006 | EP1638947A2 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1 |
| 03/29/2006 | EP1638944A1 Tachykinin receptor antagonists |